nodes	percent_of_prediction	percent_of_DWPC	metapath
Etravirine—ABCB1—Methylprednisolone—psoriatic arthritis	0.102	0.131	CbGbCtD
Etravirine—CYP2C19—Prednisone—psoriatic arthritis	0.0766	0.0987	CbGbCtD
Etravirine—ABCB1—Betamethasone—psoriatic arthritis	0.0664	0.0855	CbGbCtD
Etravirine—ABCB1—Prednisolone—psoriatic arthritis	0.0655	0.0843	CbGbCtD
Etravirine—ABCB1—Prednisone—psoriatic arthritis	0.0618	0.0797	CbGbCtD
Etravirine—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0612	0.0788	CbGbCtD
Etravirine—CYP2C19—Dexamethasone—psoriatic arthritis	0.0479	0.0616	CbGbCtD
Etravirine—CYP3A4—Triamcinolone—psoriatic arthritis	0.0464	0.0597	CbGbCtD
Etravirine—CYP2C9—Dexamethasone—psoriatic arthritis	0.0398	0.0512	CbGbCtD
Etravirine—CYP3A4—Betamethasone—psoriatic arthritis	0.0398	0.0512	CbGbCtD
Etravirine—CYP3A4—Prednisolone—psoriatic arthritis	0.0392	0.0505	CbGbCtD
Etravirine—ABCB1—Dexamethasone—psoriatic arthritis	0.0386	0.0497	CbGbCtD
Etravirine—CYP3A4—Prednisone—psoriatic arthritis	0.0371	0.0477	CbGbCtD
Etravirine—ABCB1—Methotrexate—psoriatic arthritis	0.031	0.04	CbGbCtD
Etravirine—CYP3A4—Dexamethasone—psoriatic arthritis	0.0231	0.0298	CbGbCtD
Etravirine—Neuropathy peripheral—Prednisone—psoriatic arthritis	0.000513	0.0023	CcSEcCtD
Etravirine—Myocardial infarction—Prednisone—psoriatic arthritis	0.000513	0.0023	CcSEcCtD
Etravirine—Breast disorder—Methotrexate—psoriatic arthritis	0.000513	0.00229	CcSEcCtD
Etravirine—Toxic epidermal necrolysis—Methotrexate—psoriatic arthritis	0.000511	0.00229	CcSEcCtD
Etravirine—Malaise—Prednisolone—psoriatic arthritis	0.000508	0.00227	CcSEcCtD
Etravirine—Vertigo—Prednisolone—psoriatic arthritis	0.000506	0.00226	CcSEcCtD
Etravirine—Syncope—Prednisolone—psoriatic arthritis	0.000505	0.00226	CcSEcCtD
Etravirine—Eye disorder—Dexamethasone—psoriatic arthritis	0.000504	0.00226	CcSEcCtD
Etravirine—Eye disorder—Betamethasone—psoriatic arthritis	0.000504	0.00226	CcSEcCtD
Etravirine—Loss of consciousness—Prednisolone—psoriatic arthritis	0.000495	0.00221	CcSEcCtD
Etravirine—Angiopathy—Betamethasone—psoriatic arthritis	0.00049	0.00219	CcSEcCtD
Etravirine—Angiopathy—Dexamethasone—psoriatic arthritis	0.00049	0.00219	CcSEcCtD
Etravirine—Convulsion—Prednisolone—psoriatic arthritis	0.000488	0.00218	CcSEcCtD
Etravirine—Hypertension—Prednisolone—psoriatic arthritis	0.000486	0.00217	CcSEcCtD
Etravirine—Eosinophilia—Methotrexate—psoriatic arthritis	0.000486	0.00217	CcSEcCtD
Etravirine—Pancreatitis—Methotrexate—psoriatic arthritis	0.000481	0.00215	CcSEcCtD
Etravirine—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.00048	0.00215	CcSEcCtD
Etravirine—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.000479	0.00214	CcSEcCtD
Etravirine—Discomfort—Prednisolone—psoriatic arthritis	0.000474	0.00212	CcSEcCtD
Etravirine—Angioedema—Triamcinolone—psoriatic arthritis	0.000473	0.00212	CcSEcCtD
Etravirine—Angioedema—Methylprednisolone—psoriatic arthritis	0.000472	0.00211	CcSEcCtD
Etravirine—Malaise—Triamcinolone—psoriatic arthritis	0.000467	0.00209	CcSEcCtD
Etravirine—Malaise—Methylprednisolone—psoriatic arthritis	0.000466	0.00208	CcSEcCtD
Etravirine—Vertigo—Triamcinolone—psoriatic arthritis	0.000465	0.00208	CcSEcCtD
Etravirine—Syncope—Triamcinolone—psoriatic arthritis	0.000464	0.00208	CcSEcCtD
Etravirine—Vertigo—Methylprednisolone—psoriatic arthritis	0.000464	0.00208	CcSEcCtD
Etravirine—Syncope—Methylprednisolone—psoriatic arthritis	0.000463	0.00207	CcSEcCtD
Etravirine—Connective tissue disorder—Prednisone—psoriatic arthritis	0.000462	0.00207	CcSEcCtD
Etravirine—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.000455	0.00204	CcSEcCtD
Etravirine—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.000454	0.00203	CcSEcCtD
Etravirine—Shock—Prednisolone—psoriatic arthritis	0.000452	0.00202	CcSEcCtD
Etravirine—Convulsion—Triamcinolone—psoriatic arthritis	0.000449	0.00201	CcSEcCtD
Etravirine—Convulsion—Methylprednisolone—psoriatic arthritis	0.000448	0.002	CcSEcCtD
Etravirine—Hypertension—Triamcinolone—psoriatic arthritis	0.000447	0.002	CcSEcCtD
Etravirine—Hypertension—Methylprednisolone—psoriatic arthritis	0.000446	0.00199	CcSEcCtD
Etravirine—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.000444	0.00199	CcSEcCtD
Etravirine—Eye disorder—Prednisone—psoriatic arthritis	0.000439	0.00196	CcSEcCtD
Etravirine—Anxiety—Methylprednisolone—psoriatic arthritis	0.000438	0.00196	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000437	0.00195	CcSEcCtD
Etravirine—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000436	0.00195	CcSEcCtD
Etravirine—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000436	0.00195	CcSEcCtD
Etravirine—Discomfort—Triamcinolone—psoriatic arthritis	0.000435	0.00195	CcSEcCtD
Etravirine—Discomfort—Methylprednisolone—psoriatic arthritis	0.000435	0.00194	CcSEcCtD
Etravirine—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.000434	0.00194	CcSEcCtD
Etravirine—Dry mouth—Triamcinolone—psoriatic arthritis	0.000431	0.00193	CcSEcCtD
Etravirine—Renal failure—Methotrexate—psoriatic arthritis	0.00043	0.00192	CcSEcCtD
Etravirine—Angioedema—Betamethasone—psoriatic arthritis	0.000429	0.00192	CcSEcCtD
Etravirine—Angioedema—Dexamethasone—psoriatic arthritis	0.000429	0.00192	CcSEcCtD
Etravirine—Stomatitis—Methotrexate—psoriatic arthritis	0.000426	0.00191	CcSEcCtD
Etravirine—Angiopathy—Prednisone—psoriatic arthritis	0.000426	0.00191	CcSEcCtD
Etravirine—Conjunctivitis—Methotrexate—psoriatic arthritis	0.000425	0.0019	CcSEcCtD
Etravirine—Confusional state—Methylprednisolone—psoriatic arthritis	0.000425	0.0019	CcSEcCtD
Etravirine—Immune system disorder—Prednisone—psoriatic arthritis	0.000424	0.0019	CcSEcCtD
Etravirine—Malaise—Dexamethasone—psoriatic arthritis	0.000424	0.00189	CcSEcCtD
Etravirine—Malaise—Betamethasone—psoriatic arthritis	0.000424	0.00189	CcSEcCtD
Etravirine—Vertigo—Betamethasone—psoriatic arthritis	0.000422	0.00189	CcSEcCtD
Etravirine—Vertigo—Dexamethasone—psoriatic arthritis	0.000422	0.00189	CcSEcCtD
Etravirine—Syncope—Dexamethasone—psoriatic arthritis	0.000421	0.00188	CcSEcCtD
Etravirine—Syncope—Betamethasone—psoriatic arthritis	0.000421	0.00188	CcSEcCtD
Etravirine—Infection—Triamcinolone—psoriatic arthritis	0.00042	0.00188	CcSEcCtD
Etravirine—Infection—Methylprednisolone—psoriatic arthritis	0.000419	0.00187	CcSEcCtD
Etravirine—Shock—Triamcinolone—psoriatic arthritis	0.000416	0.00186	CcSEcCtD
Etravirine—Insomnia—Prednisolone—psoriatic arthritis	0.000416	0.00186	CcSEcCtD
Etravirine—Shock—Methylprednisolone—psoriatic arthritis	0.000415	0.00186	CcSEcCtD
Etravirine—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000414	0.00185	CcSEcCtD
Etravirine—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000413	0.00185	CcSEcCtD
Etravirine—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000413	0.00185	CcSEcCtD
Etravirine—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000413	0.00185	CcSEcCtD
Etravirine—Paraesthesia—Prednisolone—psoriatic arthritis	0.000413	0.00185	CcSEcCtD
Etravirine—Mental disorder—Prednisone—psoriatic arthritis	0.000412	0.00184	CcSEcCtD
Etravirine—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00041	0.00183	CcSEcCtD
Etravirine—Malnutrition—Prednisone—psoriatic arthritis	0.000409	0.00183	CcSEcCtD
Etravirine—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000408	0.00183	CcSEcCtD
Etravirine—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000408	0.00182	CcSEcCtD
Etravirine—Convulsion—Betamethasone—psoriatic arthritis	0.000407	0.00182	CcSEcCtD
Etravirine—Convulsion—Dexamethasone—psoriatic arthritis	0.000407	0.00182	CcSEcCtD
Etravirine—Hypertension—Dexamethasone—psoriatic arthritis	0.000406	0.00181	CcSEcCtD
Etravirine—Hypertension—Betamethasone—psoriatic arthritis	0.000406	0.00181	CcSEcCtD
Etravirine—Anxiety—Betamethasone—psoriatic arthritis	0.000399	0.00178	CcSEcCtD
Etravirine—Anxiety—Dexamethasone—psoriatic arthritis	0.000399	0.00178	CcSEcCtD
Etravirine—Discomfort—Dexamethasone—psoriatic arthritis	0.000395	0.00177	CcSEcCtD
Etravirine—Discomfort—Betamethasone—psoriatic arthritis	0.000395	0.00177	CcSEcCtD
Etravirine—Pain—Prednisolone—psoriatic arthritis	0.000393	0.00176	CcSEcCtD
Etravirine—Hepatitis—Methotrexate—psoriatic arthritis	0.000393	0.00176	CcSEcCtD
Etravirine—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000388	0.00173	CcSEcCtD
Etravirine—Vision blurred—Prednisone—psoriatic arthritis	0.000386	0.00172	CcSEcCtD
Etravirine—Urethral disorder—Methotrexate—psoriatic arthritis	0.000385	0.00172	CcSEcCtD
Etravirine—Insomnia—Triamcinolone—psoriatic arthritis	0.000382	0.00171	CcSEcCtD
Etravirine—Insomnia—Methylprednisolone—psoriatic arthritis	0.000381	0.00171	CcSEcCtD
Etravirine—Infection—Dexamethasone—psoriatic arthritis	0.000381	0.0017	CcSEcCtD
Etravirine—Infection—Betamethasone—psoriatic arthritis	0.000381	0.0017	CcSEcCtD
Etravirine—Ill-defined disorder—Prednisone—psoriatic arthritis	0.00038	0.0017	CcSEcCtD
Etravirine—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000379	0.0017	CcSEcCtD
Etravirine—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000379	0.00169	CcSEcCtD
Etravirine—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000379	0.00169	CcSEcCtD
Etravirine—Anaemia—Prednisone—psoriatic arthritis	0.000378	0.00169	CcSEcCtD
Etravirine—Shock—Dexamethasone—psoriatic arthritis	0.000377	0.00169	CcSEcCtD
Etravirine—Shock—Betamethasone—psoriatic arthritis	0.000377	0.00169	CcSEcCtD
Etravirine—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000376	0.00168	CcSEcCtD
Etravirine—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000376	0.00168	CcSEcCtD
Etravirine—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000375	0.00168	CcSEcCtD
Etravirine—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000375	0.00168	CcSEcCtD
Etravirine—Angioedema—Prednisone—psoriatic arthritis	0.000374	0.00167	CcSEcCtD
Etravirine—Erythema multiforme—Methotrexate—psoriatic arthritis	0.000371	0.00166	CcSEcCtD
Etravirine—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000371	0.00166	CcSEcCtD
Etravirine—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000371	0.00166	CcSEcCtD
Etravirine—Malaise—Prednisone—psoriatic arthritis	0.000369	0.00165	CcSEcCtD
Etravirine—Vertigo—Prednisone—psoriatic arthritis	0.000368	0.00164	CcSEcCtD
Etravirine—Eye disorder—Methotrexate—psoriatic arthritis	0.000367	0.00164	CcSEcCtD
Etravirine—Syncope—Prednisone—psoriatic arthritis	0.000367	0.00164	CcSEcCtD
Etravirine—Anorexia—Dexamethasone—psoriatic arthritis	0.000365	0.00163	CcSEcCtD
Etravirine—Anorexia—Betamethasone—psoriatic arthritis	0.000365	0.00163	CcSEcCtD
Etravirine—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000365	0.00163	CcSEcCtD
Etravirine—Fatigue—Triamcinolone—psoriatic arthritis	0.000364	0.00163	CcSEcCtD
Etravirine—Fatigue—Methylprednisolone—psoriatic arthritis	0.000363	0.00163	CcSEcCtD
Etravirine—Pain—Triamcinolone—psoriatic arthritis	0.000361	0.00162	CcSEcCtD
Etravirine—Loss of consciousness—Prednisone—psoriatic arthritis	0.00036	0.00161	CcSEcCtD
Etravirine—Angiopathy—Methotrexate—psoriatic arthritis	0.000356	0.00159	CcSEcCtD
Etravirine—Immune system disorder—Methotrexate—psoriatic arthritis	0.000355	0.00159	CcSEcCtD
Etravirine—Convulsion—Prednisone—psoriatic arthritis	0.000354	0.00159	CcSEcCtD
Etravirine—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000354	0.00158	CcSEcCtD
Etravirine—Hypertension—Prednisone—psoriatic arthritis	0.000353	0.00158	CcSEcCtD
Etravirine—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000348	0.00156	CcSEcCtD
Etravirine—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000347	0.00155	CcSEcCtD
Etravirine—Anxiety—Prednisone—psoriatic arthritis	0.000347	0.00155	CcSEcCtD
Etravirine—Insomnia—Betamethasone—psoriatic arthritis	0.000347	0.00155	CcSEcCtD
Etravirine—Insomnia—Dexamethasone—psoriatic arthritis	0.000347	0.00155	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000346	0.00155	CcSEcCtD
Etravirine—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000345	0.00154	CcSEcCtD
Etravirine—Paraesthesia—Betamethasone—psoriatic arthritis	0.000344	0.00154	CcSEcCtD
Etravirine—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000344	0.00154	CcSEcCtD
Etravirine—Discomfort—Prednisone—psoriatic arthritis	0.000344	0.00154	CcSEcCtD
Etravirine—Mental disorder—Methotrexate—psoriatic arthritis	0.000344	0.00154	CcSEcCtD
Etravirine—Malnutrition—Methotrexate—psoriatic arthritis	0.000342	0.00153	CcSEcCtD
Etravirine—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000339	0.00151	CcSEcCtD
Etravirine—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000334	0.00149	CcSEcCtD
Etravirine—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000333	0.00149	CcSEcCtD
Etravirine—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000333	0.00149	CcSEcCtD
Etravirine—Decreased appetite—Betamethasone—psoriatic arthritis	0.000333	0.00149	CcSEcCtD
Etravirine—Infection—Prednisone—psoriatic arthritis	0.000332	0.00148	CcSEcCtD
Etravirine—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000331	0.00148	CcSEcCtD
Etravirine—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000331	0.00148	CcSEcCtD
Etravirine—Fatigue—Dexamethasone—psoriatic arthritis	0.000331	0.00148	CcSEcCtD
Etravirine—Fatigue—Betamethasone—psoriatic arthritis	0.000331	0.00148	CcSEcCtD
Etravirine—Shock—Prednisone—psoriatic arthritis	0.000328	0.00147	CcSEcCtD
Etravirine—Pain—Dexamethasone—psoriatic arthritis	0.000328	0.00147	CcSEcCtD
Etravirine—Pain—Betamethasone—psoriatic arthritis	0.000328	0.00147	CcSEcCtD
Etravirine—Nervous system disorder—Prednisone—psoriatic arthritis	0.000327	0.00146	CcSEcCtD
Etravirine—Skin disorder—Prednisone—psoriatic arthritis	0.000324	0.00145	CcSEcCtD
Etravirine—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000323	0.00144	CcSEcCtD
Etravirine—Vision blurred—Methotrexate—psoriatic arthritis	0.000322	0.00144	CcSEcCtD
Etravirine—Anorexia—Prednisone—psoriatic arthritis	0.000318	0.00142	CcSEcCtD
Etravirine—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000317	0.00142	CcSEcCtD
Etravirine—Anaemia—Methotrexate—psoriatic arthritis	0.000316	0.00141	CcSEcCtD
Etravirine—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000316	0.00141	CcSEcCtD
Etravirine—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000316	0.00141	CcSEcCtD
Etravirine—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000314	0.0014	CcSEcCtD
Etravirine—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000314	0.0014	CcSEcCtD
Etravirine—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000311	0.00139	CcSEcCtD
Etravirine—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000311	0.00139	CcSEcCtD
Etravirine—Malaise—Methotrexate—psoriatic arthritis	0.000308	0.00138	CcSEcCtD
Etravirine—Vertigo—Methotrexate—psoriatic arthritis	0.000307	0.00137	CcSEcCtD
Etravirine—Dizziness—Prednisolone—psoriatic arthritis	0.000304	0.00136	CcSEcCtD
Etravirine—Asthenia—Triamcinolone—psoriatic arthritis	0.000303	0.00136	CcSEcCtD
Etravirine—Body temperature increased—Betamethasone—psoriatic arthritis	0.000303	0.00136	CcSEcCtD
Etravirine—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000303	0.00136	CcSEcCtD
Etravirine—Abdominal pain—Betamethasone—psoriatic arthritis	0.000303	0.00136	CcSEcCtD
Etravirine—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000303	0.00136	CcSEcCtD
Etravirine—Asthenia—Methylprednisolone—psoriatic arthritis	0.000302	0.00135	CcSEcCtD
Etravirine—Insomnia—Prednisone—psoriatic arthritis	0.000302	0.00135	CcSEcCtD
Etravirine—Paraesthesia—Prednisone—psoriatic arthritis	0.0003	0.00134	CcSEcCtD
Etravirine—Convulsion—Methotrexate—psoriatic arthritis	0.000296	0.00132	CcSEcCtD
Etravirine—Decreased appetite—Prednisone—psoriatic arthritis	0.00029	0.0013	CcSEcCtD
Etravirine—Rash—Prednisolone—psoriatic arthritis	0.00029	0.0013	CcSEcCtD
Etravirine—Dermatitis—Prednisolone—psoriatic arthritis	0.000289	0.00129	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000289	0.00129	CcSEcCtD
Etravirine—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000288	0.00129	CcSEcCtD
Etravirine—Fatigue—Prednisone—psoriatic arthritis	0.000288	0.00129	CcSEcCtD
Etravirine—Headache—Prednisolone—psoriatic arthritis	0.000288	0.00129	CcSEcCtD
Etravirine—Discomfort—Methotrexate—psoriatic arthritis	0.000288	0.00129	CcSEcCtD
Etravirine—Constipation—Prednisone—psoriatic arthritis	0.000286	0.00128	CcSEcCtD
Etravirine—Confusional state—Methotrexate—psoriatic arthritis	0.000281	0.00126	CcSEcCtD
Etravirine—Dizziness—Triamcinolone—psoriatic arthritis	0.000279	0.00125	CcSEcCtD
Etravirine—Dizziness—Methylprednisolone—psoriatic arthritis	0.000279	0.00125	CcSEcCtD
Etravirine—Infection—Methotrexate—psoriatic arthritis	0.000277	0.00124	CcSEcCtD
Etravirine—Feeling abnormal—Prednisone—psoriatic arthritis	0.000275	0.00123	CcSEcCtD
Etravirine—Asthenia—Betamethasone—psoriatic arthritis	0.000275	0.00123	CcSEcCtD
Etravirine—Asthenia—Dexamethasone—psoriatic arthritis	0.000275	0.00123	CcSEcCtD
Etravirine—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000274	0.00122	CcSEcCtD
Etravirine—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000273	0.00122	CcSEcCtD
Etravirine—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000273	0.00122	CcSEcCtD
Etravirine—Nausea—Prednisolone—psoriatic arthritis	0.000273	0.00122	CcSEcCtD
Etravirine—Skin disorder—Methotrexate—psoriatic arthritis	0.000271	0.00121	CcSEcCtD
Etravirine—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.00027	0.00121	CcSEcCtD
Etravirine—Vomiting—Triamcinolone—psoriatic arthritis	0.000269	0.0012	CcSEcCtD
Etravirine—Vomiting—Methylprednisolone—psoriatic arthritis	0.000268	0.0012	CcSEcCtD
Etravirine—Rash—Triamcinolone—psoriatic arthritis	0.000266	0.00119	CcSEcCtD
Etravirine—Dermatitis—Triamcinolone—psoriatic arthritis	0.000266	0.00119	CcSEcCtD
Etravirine—Anorexia—Methotrexate—psoriatic arthritis	0.000266	0.00119	CcSEcCtD
Etravirine—Rash—Methylprednisolone—psoriatic arthritis	0.000266	0.00119	CcSEcCtD
Etravirine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000266	0.00119	CcSEcCtD
Etravirine—Headache—Triamcinolone—psoriatic arthritis	0.000265	0.00118	CcSEcCtD
Etravirine—Headache—Methylprednisolone—psoriatic arthritis	0.000264	0.00118	CcSEcCtD
Etravirine—Abdominal pain—Prednisone—psoriatic arthritis	0.000264	0.00118	CcSEcCtD
Etravirine—Body temperature increased—Prednisone—psoriatic arthritis	0.000264	0.00118	CcSEcCtD
Etravirine—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000262	0.00117	CcSEcCtD
Etravirine—Diarrhoea—Betamethasone—psoriatic arthritis	0.000262	0.00117	CcSEcCtD
Etravirine—Dizziness—Dexamethasone—psoriatic arthritis	0.000254	0.00113	CcSEcCtD
Etravirine—Dizziness—Betamethasone—psoriatic arthritis	0.000254	0.00113	CcSEcCtD
Etravirine—Insomnia—Methotrexate—psoriatic arthritis	0.000252	0.00113	CcSEcCtD
Etravirine—Nausea—Triamcinolone—psoriatic arthritis	0.000251	0.00112	CcSEcCtD
Etravirine—Paraesthesia—Methotrexate—psoriatic arthritis	0.000251	0.00112	CcSEcCtD
Etravirine—Nausea—Methylprednisolone—psoriatic arthritis	0.00025	0.00112	CcSEcCtD
Etravirine—Somnolence—Methotrexate—psoriatic arthritis	0.000248	0.00111	CcSEcCtD
Etravirine—Hypersensitivity—Prednisone—psoriatic arthritis	0.000246	0.0011	CcSEcCtD
Etravirine—Vomiting—Dexamethasone—psoriatic arthritis	0.000244	0.00109	CcSEcCtD
Etravirine—Vomiting—Betamethasone—psoriatic arthritis	0.000244	0.00109	CcSEcCtD
Etravirine—Decreased appetite—Methotrexate—psoriatic arthritis	0.000243	0.00108	CcSEcCtD
Etravirine—Rash—Dexamethasone—psoriatic arthritis	0.000242	0.00108	CcSEcCtD
Etravirine—Rash—Betamethasone—psoriatic arthritis	0.000242	0.00108	CcSEcCtD
Etravirine—Dermatitis—Dexamethasone—psoriatic arthritis	0.000242	0.00108	CcSEcCtD
Etravirine—Dermatitis—Betamethasone—psoriatic arthritis	0.000242	0.00108	CcSEcCtD
Etravirine—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000241	0.00108	CcSEcCtD
Etravirine—Fatigue—Methotrexate—psoriatic arthritis	0.000241	0.00108	CcSEcCtD
Etravirine—Headache—Dexamethasone—psoriatic arthritis	0.00024	0.00107	CcSEcCtD
Etravirine—Headache—Betamethasone—psoriatic arthritis	0.00024	0.00107	CcSEcCtD
Etravirine—Asthenia—Prednisone—psoriatic arthritis	0.00024	0.00107	CcSEcCtD
Etravirine—Pain—Methotrexate—psoriatic arthritis	0.000239	0.00107	CcSEcCtD
Etravirine—Feeling abnormal—Methotrexate—psoriatic arthritis	0.00023	0.00103	CcSEcCtD
Etravirine—Diarrhoea—Prednisone—psoriatic arthritis	0.000228	0.00102	CcSEcCtD
Etravirine—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000228	0.00102	CcSEcCtD
Etravirine—Nausea—Betamethasone—psoriatic arthritis	0.000228	0.00102	CcSEcCtD
Etravirine—Nausea—Dexamethasone—psoriatic arthritis	0.000228	0.00102	CcSEcCtD
Etravirine—Dizziness—Prednisone—psoriatic arthritis	0.000221	0.000987	CcSEcCtD
Etravirine—Abdominal pain—Methotrexate—psoriatic arthritis	0.000221	0.000987	CcSEcCtD
Etravirine—Body temperature increased—Methotrexate—psoriatic arthritis	0.000221	0.000987	CcSEcCtD
Etravirine—Vomiting—Prednisone—psoriatic arthritis	0.000212	0.000949	CcSEcCtD
Etravirine—Rash—Prednisone—psoriatic arthritis	0.000211	0.000942	CcSEcCtD
Etravirine—Dermatitis—Prednisone—psoriatic arthritis	0.00021	0.000941	CcSEcCtD
Etravirine—Headache—Prednisone—psoriatic arthritis	0.000209	0.000935	CcSEcCtD
Etravirine—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000206	0.000919	CcSEcCtD
Etravirine—Asthenia—Methotrexate—psoriatic arthritis	0.0002	0.000895	CcSEcCtD
Etravirine—Nausea—Prednisone—psoriatic arthritis	0.000198	0.000887	CcSEcCtD
Etravirine—Diarrhoea—Methotrexate—psoriatic arthritis	0.000191	0.000854	CcSEcCtD
Etravirine—Dizziness—Methotrexate—psoriatic arthritis	0.000185	0.000825	CcSEcCtD
Etravirine—Vomiting—Methotrexate—psoriatic arthritis	0.000177	0.000793	CcSEcCtD
Etravirine—Rash—Methotrexate—psoriatic arthritis	0.000176	0.000787	CcSEcCtD
Etravirine—Dermatitis—Methotrexate—psoriatic arthritis	0.000176	0.000786	CcSEcCtD
Etravirine—Headache—Methotrexate—psoriatic arthritis	0.000175	0.000782	CcSEcCtD
Etravirine—Nausea—Methotrexate—psoriatic arthritis	0.000166	0.000741	CcSEcCtD
